Search Results - "Kellier‐Steele, Nicole"
-
1
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15‐Year US Postmarketing Surveillance Study
Published in Journal of bone and mineral research (01-02-2021)“…ABSTRACT The Osteosarcoma Surveillance Study was initiated in the United States in 2003 to monitor for a potential association between the osteoporosis…”
Get full text
Journal Article -
2
Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data
Published in Pharmacoepidemiology and drug safety (01-12-2020)“…Purpose During preclinical testing, teriparatide caused a dose‐dependent increase in the incidence of osteosarcoma in rats. This study compared the incidence…”
Get full text
Journal Article -
3
Teriparatide and Osteosarcoma Risk: History, Science, Elimination of Boxed Warning, and Other Label Updates
Published in JBMR plus (01-09-2022)“…ABSTRACT The phase 3 trials of the bone anabolic drug teriparatide were prematurely terminated because of a preclinical finding of osteosarcoma in rats treated…”
Get full text
Journal Article -
4
Assessing the incidence of osteosarcoma among teriparatide-treated patients using linkage of commercial pharmacy and state cancer registry data, contributing to the removal of boxed warning and other labeling changes
Published in Bone (New York, N.Y.) (01-07-2022)“…Teriparatide, a recombinant human parathyroid hormone analogue, is associated with increased bone mineral density and a decreased risk of fractures. A…”
Get full text
Journal Article -
5
-
6
Post-Marketing Case Series Study of Adult Osteosarcoma and for(s)teo: Study Update from the First 12 Years
Published in Journal of clinical densitometry (01-10-2016)Get full text
Journal Article